1. Home
  2. KROS vs EE Comparison

KROS vs EE Comparison

Compare KROS & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • EE
  • Stock Information
  • Founded
  • KROS 2015
  • EE 2003
  • Country
  • KROS United States
  • EE United States
  • Employees
  • KROS N/A
  • EE N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • EE Oil/Gas Transmission
  • Sector
  • KROS Health Care
  • EE Utilities
  • Exchange
  • KROS Nasdaq
  • EE Nasdaq
  • Market Cap
  • KROS 460.6M
  • EE 588.7M
  • IPO Year
  • KROS 2020
  • EE 2022
  • Fundamental
  • Price
  • KROS $11.12
  • EE $30.94
  • Analyst Decision
  • KROS Buy
  • EE Hold
  • Analyst Count
  • KROS 11
  • EE 6
  • Target Price
  • KROS $45.33
  • EE $31.00
  • AVG Volume (30 Days)
  • KROS 2.1M
  • EE 208.6K
  • Earning Date
  • KROS 02-26-2025
  • EE 02-26-2025
  • Dividend Yield
  • KROS N/A
  • EE 0.44%
  • EPS Growth
  • KROS N/A
  • EE N/A
  • EPS
  • KROS N/A
  • EE 0.94
  • Revenue
  • KROS $651,000.00
  • EE $816,929,000.00
  • Revenue This Year
  • KROS $303.27
  • EE N/A
  • Revenue Next Year
  • KROS N/A
  • EE $2.41
  • P/E Ratio
  • KROS N/A
  • EE $32.66
  • Revenue Growth
  • KROS 8037.50
  • EE N/A
  • 52 Week Low
  • KROS $9.78
  • EE $13.38
  • 52 Week High
  • KROS $73.00
  • EE $32.99
  • Technical
  • Relative Strength Index (RSI)
  • KROS 25.01
  • EE 47.37
  • Support Level
  • KROS $11.04
  • EE $28.85
  • Resistance Level
  • KROS $11.36
  • EE $30.30
  • Average True Range (ATR)
  • KROS 0.53
  • EE 0.98
  • MACD
  • KROS 1.15
  • EE -0.17
  • Stochastic Oscillator
  • KROS 37.80
  • EE 31.69

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About EE Excelerate Energy Inc.

Excelerate Energy Inc is engaged in flexible LNG solutions, providing integrated services along the LNG value chain. The company offers a full range of flexible regasification services from FSRUs to infrastructure development, to LNG and natural gas supply.

Share on Social Networks: